N

Nurix Therapeutics

Drug discovery targeting ubiquitin E3 ligases

Director Quality Assurance

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeBrisbane, CA, USA$228.1k - $252k

About the Job

Requirements

  • A bachelor's degree in chemistry, pharmaceutical sciences, life sciences, or a related field.
  • At least 12 years of progressive Quality Assurance experience in the pharmaceutical or biopharmaceutical industry, including experience in a formal leadership role.
  • Deep technical expertise in GMP requirements for small molecule drug substances and drug products across clinical development stages.
  • Demonstrated experience managing CDMO relationships and overseeing quality operations at contract manufacturing and laboratory organizations.
  • Thorough knowledge of FDA regulations (21 CFR Parts 210/211), ICH guidelines (Q7, Q8, Q9, Q10, Q11), and EudraLex Volume 4 (GMP), and their practical application to CMC development.
  • A proven track record managing quality events, deviations, CAPA programs, and change control in a clinical or commercial pharmaceutical setting.
  • Demonstrated ability to lead, develop, and motivate Quality Assurance teams in a fast-paced, ambiguous, clinical-stage environment.
  • Project management skills, including the ability to manage multiple high-priority deliverables simultaneously.
  • Verbal and written communication skills sufficient to present complex quality and compliance topics clearly to diverse stakeholders, including executive leadership.
  • Willingness to travel to CDMO and laboratory sites domestically and internationally as needed.

Responsibilities

  • Provide strategic quality leadership for CMC development programs, ensuring GMP compliance with FDA, ex-US regulatory authorities, and ICH guidelines across drug substance and drug product development.
  • Serve as the primary quality interface with CDMOs and contract laboratories, overseeing review and approval of deviations, investigations, batch records, lot disposition, technical protocols and reports, methods, and specifications.
  • Lead and develop a team of Quality Assurance professionals; set clear performance expectations, mentor, and build organizational capability to support pipeline advancement and commercialization readiness.
  • Drive timely identification, investigation, and resolution of quality events and deviations, and oversee CAPA execution and effectiveness verification to prevent recurrence.
  • Support the change control process, ensuring changes affecting manufacturing, testing, and regulatory filings are captured, and escalate issues with broad cross-functional impact.
  • Support regulatory inspection readiness; serve as a quality representative during FDA, EMA, and other agency inspections and develop observation responses.
  • Contribute to CMC sections of regulatory filings (INDs, NDAs/BLAs) in partnership with Regulatory Affairs, and partner with CMC and Regulatory Affairs to align quality deliverables with pipeline milestones and program timelines.
  • Support implementation and optimization of the electronic quality management system (eQMS) platform and contribute to system improvement initiatives.
  • Maintain current knowledge of evolving regulatory expectations and industry standards, and translate requirements into practical operational guidance for the organization.

Desired Qualifications

  • Experience supporting or leading regulatory agency inspections (FDA, EMA, or equivalent); experience as lead QA representative during pre-approval inspections is preferred.
  • Experience in a clinical-stage biotech environment scaling quality operations through late-stage development and toward commercialization.
  • Experience with electronic QMS platforms (e.g., Veeva Vault) and document management systems.
  • Expertise in both development-phase and pre-commercial-phase quality assurance standards and expectations.

About the Company

Nurix Therapeutics

Drug discovery targeting ubiquitin E3 ligases

Nurix Therapeutics develops drugs that use the body's own protein-degradation system to treat diseases. Its core approach is to control ubiquitin E3 ligases, enzymes that tag unwanted proteins for breakdown in cells. By modulating these ligases, Nurix aims to create therapeutics, especially small-molecule immuno-oncology agents, that can selectively remove disease-related proteins in cancer and other serious conditions. The company operates by discovering and developing drug candidates and earning revenue through partnerships, licensing, and potential future sales of its medicines. Unlike many biotech firms that target single proteins, Nurix focuses on the protein-degradation pathway to influence multiple disease processes through carefully designed molecules. The goal is to bring new cancer treatments and other therapies to patients by advancing its degrader-based drugs through research, collaboration, and development toward commercial use.

Company size
201-500
Company stage
IPO
Headquarters
Brisbane, CA
Founded
2012

Recently Posted Jobs

Explore more opportunities at Nurix Therapeutics

See more jobs